Pine Labs could be a significant beneficiary of the MDR

From 15 October 2026, NPCI's new framework introduces 0.4% MDR on eligible UPI P2M transactions above ₹2,000. Customers won't pay the fee; the revenue is shared within the payment ecosystem. High-value transactions are particularly important because transactions above ₹2,000 represented only about 4% of P2M volumes but around 68% of transaction value in July, according to JM Financial. For Pine Labs, the key benefit is its role as a merchant acquirer/payment-acceptance platform. Pine Labs provides merchants with UPI acquiring rails, QR payments and payment-processing infrastructure, so eligible high-value UPI transactions flowing through its merchant network can create a new recurring revenue stream. Brokerage estimates are quite meaningful: Jefferies estimates Pine Labs could generate approximately ₹160 crore incremental UPI-MDR revenue in FY28, potentially equivalent to around 20% of its FY28 EBIT/PBT estimates. Emkay estimates around ₹155 crore of FY28 UPI-MDR revenue using a conservative 6-bps realised take rate. These are analyst estimates, not company guidance.